Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
OCUL
|
Donald Notman
Officer |
SELL
Open market or private sale
|
Direct | 6,301 Reduced 2.99% |
$49,399
$7.84 p/Share
|
Jan 31
2025 |
|
LICY
|
Christopher J. Biederman
Chief Technology Officer |
SELL
Open market or private sale
|
Direct | 326 Reduced 0.36% |
$329
$1.01 p/Share
|
Jan 31
2025 |
|
LICY
|
Carl De Luca |
SELL
Open market or private sale
|
Direct | 391 Reduced 0.39% |
$394
$1.01 p/Share
|
Jan 31
2025 |
|
LICY
|
Dawei Li
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 180 Reduced 0.29% |
$181
$1.01 p/Share
|
Jan 31
2025 |
|
AMTB
|
Howard A. Levine
Officer |
SELL
Open market or private sale
|
Direct | 3,628 Reduced 50.73% |
$83,589
$23.04 p/Share
|
Jan 31
2025 |
|
DMLP
|
Dorchester Minerals Operating LP |
BUY
Open market or private purchase
|
Direct | 7,500 Added 15.41% |
$237,675
$31.69 p/Share
|
Jan 31
2025 |
|
OTIS
|
Peiming Zheng
EVP, Chief Product, Delivery |
SELL
Open market or private sale
|
Direct | 32,694 Reduced 99.49% |
$3,119,334
$95.41 p/Share
|
Jan 31
2025 |
|
CUBI
|
Jay S Sidhu
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 33,173 Reduced 3.11% |
$1,899,154
$57.25 p/Share
|
Jan 31
2025 |
|
NBIX
|
Julie Cooke
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 1,740 Reduced 8.73% |
$266,028
$152.89 p/Share
|
Jan 31
2025 |
|
PNRG
|
Robert De Rothschild |
SELL
Open market or private sale
|
Indirect | 3,297 Reduced 0.0% |
$724,416
$219.72 p/Share
|
Jan 31
2025 |
|
NBIX
|
Eiry Roberts
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 1,457 Reduced 4.31% |
$222,629
$152.8 p/Share
|
Jan 31
2025 |
|
NBIX
|
Kevin Charles Gorman
Director |
SELL
Open market or private sale
|
Direct | 2,707 Reduced 0.52% |
$413,954
$152.92 p/Share
|
Jan 31
2025 |
|
NBIX
|
Jude Onyia
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 126 Reduced 0.8% |
$19,274
$152.97 p/Share
|
Jan 31
2025 |
|
NBIX
|
Ingrid Delaet
Chief Regulatory Officer |
SELL
Open market or private sale
|
Direct | 422 Reduced 12.76% |
$64,587
$153.05 p/Share
|
Jan 31
2025 |
|
NBIX
|
Kyle Gano
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 1,541 Reduced 1.11% |
$235,572
$152.87 p/Share
|
Jan 31
2025 |
|
GD
|
Laura J Schumacher |
SELL
Open market or private sale
|
Direct | 1,796 Reduced 13.85% |
$459,201
$255.68 p/Share
|
Jan 31
2025 |
|
NBIX
|
Darin Lippoldt
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 2.97% |
$191,137
$152.91 p/Share
|
Jan 31
2025 |
|
NBIX
|
David W. Boyer
Chief Corp. Affairs Officer |
SELL
Open market or private sale
|
Direct | 1,104 Reduced 44.64% |
$168,845
$152.94 p/Share
|
Jan 31
2025 |
|
NBIX
|
Eric Benevich
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 1,207 Reduced 2.8% |
$184,598
$152.94 p/Share
|
Jan 31
2025 |
|
NBIX
|
Matt Abernethy
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,283 Reduced 3.78% |
$196,132
$152.87 p/Share
|
Jan 31
2025 |
|
PLMR
|
Jon Christianson
President |
SELL
Open market or private sale
|
Direct | 356 Reduced 0.62% |
$37,205
$104.51 p/Share
|
Jan 31
2025 |
|
PLMR
|
Mac Armstrong
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 2,237 Reduced 3.23% |
$233,766
$104.5 p/Share
|
Jan 31
2025 |
|
PLMR
|
Jonathan Knutzen
Chief Risk Officer |
SELL
Open market or private sale
|
Direct | 282 Reduced 1.38% |
$29,457
$104.46 p/Share
|
Jan 31
2025 |
|
PLMR
|
Angela L. Grant
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 264 Reduced 5.08% |
$27,595
$104.53 p/Share
|
Jan 31
2025 |
|
PLMR
|
T Christopher Uchida
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 390 Reduced 2.06% |
$40,743
$104.47 p/Share
|
Jan 31
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 605,000 Added 0.0% |
$4,833,950
$7.99 p/Share
|
Jan 31
2025 |
|
DSAC
|
Josh Resnik
President and CEO |
SELL
Open market or private sale
|
Direct | 4,030 Reduced 0.33% |
$4,674
$1.16 p/Share
|
Jan 31
2025 |
|
ZNTL
|
Jan Skvarka
Director |
BUY
Open market or private purchase
|
Direct | 60,000 Added 28.63% |
$103,200
$1.72 p/Share
|
Jan 31
2025 |
|
OCX
|
Patrick W Smith
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 890 Added 0.0% |
$1,788
$2.01 p/Share
|
Jan 31
2025 |
|
SNCY
|
John Gyurci
Chief Acct. Off. & VP, Finance |
SELL
Open market or private sale
|
Direct | 164 Reduced 1.39% |
$2,804
$17.1 p/Share
|
Jan 31
2025 |
|
CRDO
|
Sutardja, Pantas
Director |
SELL
Open market or private sale
|
Direct | 1,875 Reduced 0.03% |
$125,549
$66.96 p/Share
|
Jan 31
2025 |
|
ZNTL
|
Luke Nathaniel Walker
Director |
BUY
Open market or private purchase
|
Direct | 14,200 Added 14.08% |
$24,992
$1.76 p/Share
|
Jan 31
2025 |
|
ZNTL
|
Julia Marie Eastland
CEO & President |
BUY
Open market or private purchase
|
Direct | 28,500 Added 50.0% |
$49,305
$1.73 p/Share
|
Jan 31
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 115,000 Added 0.0% |
$864,800
$7.52 p/Share
|
Jan 31
2025 |
|
HIMS
|
Andrew Dudum
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 78.18% |
$3,522,000
$35.22 p/Share
|
Jan 31
2025 |
|
IPAXW
|
Steven Vontur
Officer |
SELL
Open market or private sale
|
Direct | 9,266 Reduced 8.59% |
$208,485
$22.5 p/Share
|
Jan 31
2025 |
|
TXO
|
Brent W. Clum
Pres, Business Opers and CFO |
SELL
Open market or private sale
|
Direct | 7,702 Reduced 1.61% |
$143,180
$18.59 p/Share
|
Jan 31
2025 |
|
TXO
|
Scott T. Agosta
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 5,775 Reduced 3.49% |
$107,357
$18.59 p/Share
|
Jan 31
2025 |
|
NOTV
|
Robert Leasure Jr.
President and CEO |
SELL
Open market or private sale
|
Direct | 22,700 Reduced 2.16% |
$94,205
$4.15 p/Share
|
Jan 31
2025 |
|
DCOM
|
Basswood Capital Management, L.L.C. |
BUY
Open market or private purchase
|
Indirect | 1,043 Added 0.0% |
$32,572
$31.23 p/Share
|
Jan 31
2025 |
|
IBKR
|
Jill Bright |
BUY
Open market or private purchase
|
Direct | 135 Added 5.17% |
$29,633
$219.51 p/Share
|
Jan 31
2025 |
|
ACRE
|
Anton Feingold
Gen. Counsel VP and Secretary |
SELL
Open market or private sale
|
Direct | 7,615 Reduced 8.86% |
$43,253
$5.68 p/Share
|
Jan 31
2025 |
|
BILL
|
Germaine Cota
SVP, FINANCE & ACCOUNTING |
SELL
Open market or private sale
|
Direct | 3,938 Reduced 57.58% |
$393,800
$100.0 p/Share
|
Jan 31
2025 |
|
AZTA
|
Ginger Zhou
SVP and General Manager, Genom |
BUY
Open market or private purchase
|
Direct | 417 Added 1.47% |
$19,131
$45.88 p/Share
|
Jan 31
2025 |
|
BILL
|
Alison Wagonfeld |
SELL
Open market or private sale
|
Direct | 979 Reduced 100.0% |
$97,900
$100.0 p/Share
|
Jan 31
2025 |
|
TCBI
|
Robert W Stallings
Director |
BUY
Open market or private purchase
|
Indirect | 6,788 Added 0.0% |
$144,584
$21.3 p/Share
|
Jan 31
2025 |
|
CGTX
|
Lisa Ricciardi
CEO & President |
BUY
Open market or private purchase
|
Indirect | 38,851 Added 0.0% |
$29,915
$0.77 p/Share
|
Jan 31
2025 |
|
NOTV
|
Jeffrey Arthur Krupp
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,036 Reduced 6.55% |
$9,121
$4.48 p/Share
|
Jan 31
2025 |
|
NOTV
|
John E Sagartz
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 2,118 Reduced 0.3% |
$9,488
$4.48 p/Share
|
Jan 31
2025 |
|
ACRE
|
Jeffrey Michael Gonzales
CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 4,020 Reduced 7.34% |
$22,833
$5.68 p/Share
|
Jan 31
2025 |